The pharmaceutical trend toward increasing concentration appears to be gaining momentum. On September 15, Novartis shareholders approved the company’s proposed spinoff of Sandoz, the generics and biosimilars unit. The company anticipates the deal to close in early October. Similarly, Sanofi is also taking a scalpel to its operations, offloading a selection of its central nervous…
Aphena reveals plans for third-party logistics division
Aphena Pharma Solutions has announced the launch of a Third-Party Logistics (3PL) Division at its campus in Cookeville, Tenn. The pharmaceutical packaging and manufacturing company plans to complete the new division by the end of the year and serve new clients in early 2022. The 3PL unit will cater to the prescription pharmaceutical market, focusing…